Brief: Oncternal Therapeutics Says Entered Into Open Market Sale Agreement
17/12/2021 22:21
Dec 17 (Reuters) - Oncternal Therapeutics Inc ONCT.O :
* ONCTERNAL THERAPEUTICS INC - ON DEC 17, CO ENTERED INTO
OPEN
MARKET SALE AGREEMENT
* ONCTERNAL THERAPEUTICS INC - MAY OFFER AND SELL SHARES OF
CO'S
COMMON STOCK HAVING AN AGGREGATE OFFERING PRICE OF UP TO $50
MILLION
Further company coverage: ONCT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oncternal Therapeutics
See all newsOncternal Therapeutics Inc expected to post a loss of $3.19 a share - Earnings Preview
Brief: Oncternal Therapeutics Workforce Reduction Of About 10 Employees
U.S. STOCKS ON THE MOVE-Unity Software, Viking Holdings, Adobe
U.S. STOCKS ON THE MOVE-Gold miners, silver miners, Warner Bros Discovery
Oncternal hits record low on plans to scrap studies, explore strategic alternatives;